Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · IEX Real-Time Price · USD
10.59
+0.81 (8.28%)
At close: Apr 26, 2024, 4:00 PM
11.00
+0.41 (3.87%)
After-hours: Apr 26, 2024, 6:42 PM EDT
Shattuck Labs Revenue
In the year 2023, Shattuck Labs had annual revenue of $1.66M with 154.14% growth. Revenue in the quarter ending December 31, 2023 was $714.00K with 83.08% year-over-year growth.
Revenue (ttm)
$1.66M
Revenue Growth
+154.14%
P/S Ratio
303.90
Revenue / Employee
$22,093
Employees
75
Market Cap
503.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
Dec 31, 2018 | 22.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PetIQ | 1.10B |
Avid Bioservices | 136.74M |
Alector | 97.06M |
UroGen Pharma | 82.71M |
Verve Therapeutics | 11.76M |
IGM Biosciences | 2.13M |
Allogene Therapeutics | 95.00K |
STTK News
- 18 days ago - Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 27 days ago - Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D. - GlobeNewsWire
- 2 months ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Participation in Upcoming March Conferences - GlobeNewsWire
- 2 months ago - Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins - PRNewsWire
- 2 months ago - Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases - GlobeNewsWire
- 3 months ago - Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024 - GlobeNewsWire